+ Follow PROSPECTIVE DIABETES STUDY Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1358456
[Title] => How to prevent 1 million coronary events in diabetes
[Summary] => Aggressive control of blood pressure, lipids, and hemoglobin A1c in Americans with type 2 diabetes would prevent nearly 1 million fatal and nonfatal myocardial infarctions and sudden cardiac deaths over 10 years.
[DatePublished] => 2014-08-17 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 321958
[Title] => Economical drug available for diabetics
[Summary] => Diabetic patients will now have an easier access to a drug that would help decrease their blood sugar and reduce the risk of complications brought about by the condition.
Therapharma’s brand of glimepiride which was introduced late last year, is now part of the antidiabetic regimen of many Filipino patients with type 2 diabetes.
[DatePublished] => 2006-02-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 306158
[Title] => Therapharma launches ‘pharmacoeconomic’ glimepiride for diabetes
[Summary] => People with diabetes will now have better access to a medicine that would help lower their blood sugar and reduce the risk of complications brought about by the condition.
Therapharma, a division of United Laboratories, recently launched its brand of glimepiride, an oral medicine belonging to a class of blood sugar-lowering drugs called sulfonylurea.
Glimepiride is used in type II diabetes, the most common type of diabetes that is found in most patients with diabetes.
[DatePublished] => 2005-11-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 238617
[Title] => Protect your kidneys from diabetes
[Summary] => Majority of people with diabetes will develop severe kidney disease that could lead to kidney failure. Kidney failure is a situation in which the organs fail to filter the blood. This requires either a kidney transplant or dialysis treatment.
Diabetes is the single most common cause of end-stage renal disease (ESRD) in adults, accounting for 35-40 percent of new cases each year.
[DatePublished] => 2004-02-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
PROSPECTIVE DIABETES STUDY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1358456
[Title] => How to prevent 1 million coronary events in diabetes
[Summary] => Aggressive control of blood pressure, lipids, and hemoglobin A1c in Americans with type 2 diabetes would prevent nearly 1 million fatal and nonfatal myocardial infarctions and sudden cardiac deaths over 10 years.
[DatePublished] => 2014-08-17 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 321958
[Title] => Economical drug available for diabetics
[Summary] => Diabetic patients will now have an easier access to a drug that would help decrease their blood sugar and reduce the risk of complications brought about by the condition.
Therapharma’s brand of glimepiride which was introduced late last year, is now part of the antidiabetic regimen of many Filipino patients with type 2 diabetes.
[DatePublished] => 2006-02-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 306158
[Title] => Therapharma launches ‘pharmacoeconomic’ glimepiride for diabetes
[Summary] => People with diabetes will now have better access to a medicine that would help lower their blood sugar and reduce the risk of complications brought about by the condition.
Therapharma, a division of United Laboratories, recently launched its brand of glimepiride, an oral medicine belonging to a class of blood sugar-lowering drugs called sulfonylurea.
Glimepiride is used in type II diabetes, the most common type of diabetes that is found in most patients with diabetes.
[DatePublished] => 2005-11-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 238617
[Title] => Protect your kidneys from diabetes
[Summary] => Majority of people with diabetes will develop severe kidney disease that could lead to kidney failure. Kidney failure is a situation in which the organs fail to filter the blood. This requires either a kidney transplant or dialysis treatment.
Diabetes is the single most common cause of end-stage renal disease (ESRD) in adults, accounting for 35-40 percent of new cases each year.
[DatePublished] => 2004-02-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
February 16, 2006 - 12:00am
November 10, 2005 - 12:00am
February 12, 2004 - 12:00am
